INTRODUCTION•ESTABLISHED & BASED IN MUMBAI•MANUFACTURERS OF FILTER FABRICS USED INPHARMACEUTICALS, CHEMICALS, DYES, PIGMENTS, MININGCOMPANIES• CAPACITY OF PRODUCING 500000MTRS/DAY•2 WORLD CLASS MANUFACTURING FACILITIES IN THANE.• ABSOLUTE DOMESTIC MARKET LEADER.• BACKED WITH DEALERS NETWORK ALL OVER INDIA• COMPANY’S AVERAGE SALES GROWTH RATE SINCE ITSINCEPTION IS 12.2%
WHY SOUTH AFRICA Politically stable• Possess well-developed legal, communications, energy, transport, and financial sectors; with a stock exchange that ranks among the 10 largest in the world.• Leading Recipient of FDI• Investment Opportunities are high due to ample resources in terms of land, labour & technology
WHY SOUTH AFRICA According to our new research report " South African Healthcare Market Analysis", the pharmaceutical industry in South Africa has been continuously growing despite the concerns of drug inflation. The pharmaceutical industry future remains pleasantly buoyant and it is expected to grow at a CAGR of around 22% during 2010-2013. The optimistic outlook for the industry is based on the fact that private players are making intensive investments. Our Clientile has done huge investments in South Africa.e.g.Cipla Ltd, Lupin Ltd, GSK, Eli & Lilly etc
WHY SOUTH AFRICA INCREASING GDP PROJECTS PRONE South Africa led the subregion as foreign direct investment (FDI) inflows into sub-Saharan Africa jumped by 25% in 2011, according to the 2012 World Investment Report by the UN Conference on Trade and Development (Unctad). The report, released in Geneva, Switzerland on Thursday, shows that FDI inflows to sub-Saharan Africa soared from US$29.5-billion in 2010 to $36.9-billion in 2011, a level comparable to the peak of $37.3-billion achieved in 2008, prior to the onset of the global financial crisis. http://www.southafrica.info/business/investing/fdi- 060712.htm#.UIf0Rq5lV8U#ixzz2AE0cereC
ENTRY STRATEGYDEALERSHIPS / FRANCHISING1. Will provide marketing & technical know how to the dealers in SA2. Distribute the market among dealers geographically3. Exclusive Dealers only4. Dealers will be the small & local suppliers of filter fabrics to pharma companies5. Commissions based dealership.
SEGMENTATION STRATEGY The market will be segmented geographically so that it will be easy for a dealer to supply the products in right time.
MARKETINGDifferentiated Marketing will be done to satisfy distinct needs of every customers. Participation in exhibitions.Referrals from Indian subsidies
PRICING STRATEGYProducts will be priced reasonably low to penetrate into the marketThe main objective will be to keep new entrants away from the industryIn case of highly innovative product, the premium will be charged.
OUR U.S.PQuick After sales Service Technical expertise Low Cost